Serum amyloid A induces interleukin-1β secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome

Clinical and Experimental Immunology

Volumn 179, Issue 2, 2015, Pages 344-353

  Yu, N ^a   Liu, S ^c   Yi, X ^a   Zhang, S ^b   Ding, Y ^a  

^a Shanghai Skin Disease Hospital   (China)

^b EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

^c Taizhou Municipal Hospital   (China)

Author keywords

IL 1 ; Inflammasome; Keratinocytes; Psoriasis; Serum amyloid A

Indexed keywords

CARRIER PROTEIN; IL17A PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 1BETA; NLRP3 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; SERUM AMYLOID A; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; KERATINOCYTE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIASIS; SECRETION (PROCESS); TH17 CELL; UPREGULATION;

ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; FEMALE; HUMANS; INFLAMMASOMES; INTERLEUKIN-17; INTERLEUKIN-1BETA; KERATINOCYTES; MALE; MIDDLE AGED; PSORIASIS; REACTIVE OXYGEN SPECIES; SERUM AMYLOID A PROTEIN; TH17 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84920262939     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12458     Document Type: Article

References (38)

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361:496-509.
2. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31:331-341.
3. Zielinski CE, Mele F, Aschenbrenner D etal. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012; 484:514-518.
4. Feldmeyer L, Werner S, French LE, Beer HD. Interleukin-1, inflammasomes and the skin. Eur J Cell Biol 2010; 89:638-644.
5. Guo L, Wei G, Zhu J etal. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci USA 2009; 106:13463-13468.
6. Mills KH, Dunne A. Immune modulation: IL-1, master mediator or initiator of inflammation. Nat Med 2009; 15:1363-1364.
7. Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome. Immunol Rev 2011; 243:152-162.
8. Mills KH, Dungan LS, Jones SA, Harris J. The role of inflammasome-derived IL-1 in driving IL-17 responses. J Leukoc Biol 2013; 93:489-497.
9. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 2007; 17:1140-1145.
10. Watanabe H, Gaide O, Pétrilli V etal. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007; 127:1956-1963.
11. Sodin-Semrl S, Zigon P, Cucnik S etal. Serum amyloid A in autoimmune thrombosis. Autoimmun Rev 2006; 6:21-27.
12. Migita K, Izumi Y, Jiuchi Y etal. Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis. Clin Exp Immunol 2014; 175:208-214.
13. Dogan S, Atakan N. Is serum amyloid A protein a better indicator of inflammation in severe psoriasis? Br J Dermatol 2010; 163:895-896.
14. Migita K, Izumi Y, Jiuchi Y etal. Serum amyloid A induces NLRP-3-mediated IL-1β secretion in neutrophils. PLOS ONE 2014; 9:e96703.
15. Niemi K, Baumann MH, Kovanen PT, Eklund KK. Serum amyloid A (SAA) activates human mast cells which leads into degradation of SAA and generation of an amyloidogenic SAA fragment. Biochim Biophys Acta 2006; 1762:424-430.
16. Niemi K, Teirilä L, Lappalainen J etal. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 2011; 186:6119-6128.
17. Migita K, Koga T, Satomura K etal. Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts. Arthritis Res Ther 2012; 14:R119.
18. Connolly M, Marrelli A, Blades M etal. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 2010; 184:6427-6437.
19. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 1994; 91:3186-3190.
20. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol 2010; 40:616-619.
21. Hatanaka E, Dermargos A, Armelin HA, Curi R, Campa A. Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast. Clin Exp Immunol 2011; 163:362-367.
22. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-454.
23. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
24. King VL, Thompson J, Tannock LR. Serum amyloid A in atherosclerosis. Curr Opin Lipidol 2011; 22:302-307.
25. Chambers RE, Stross P, Barry RE, Whicher JT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest 1987; 17:460-467.
26. Ather JL, Ckless K, Martin R etal. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 2011; 187:64-73.
27. He R, Shepard LW, Chen J, Pan ZK, Ye RD. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J Immunol 2006; 177:4072-4079.
28. Rooney P, Connolly M, Gao W etal. Notch-1 mediates endothelial cell activation and invasion in psoriasis. Exp Dermatol 2014; 23:113-118.
29. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem 1998; 46:1377-1384.
30. Chung TF, Sipe JD, McKee A etal. Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid 2000; 7:105-110.
31. O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B. Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res 2000; 2:142-144.
32. Becher B, Pantelyushin S. Hiding under the skin: interleukin-17-producing γδ T cells go under the skin? Nat Med 2012; 18:1748-1750.
33. Dombrowski Y, Peric M, Koglin S etal. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 2011; 3:82ra38.
34. Dai X, Sayama K, Tohyama M etal. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol 2011; 127:806-814.
35. Carlström M, Ekman AK, Petersson S, Söderkvist P, Enerbäck C. Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Exp Dermatol 2012; 21:932-937.
36. Johansen C, Moeller K, Kragballe K, Iversen L. The activity of caspase-1 is increased in lesional psoriatic epidermis. J Invest Dermatol 2007; 127:2857-2864.
37. Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009; 47:891-905.
38. Uhlar CM, Grehan S, Steel DM, Steinkasserer A, Whitehead AS. Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6. J Immunol Methods 1997; 203:123-130.